|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.65 SEK | +0.58% |
|
+0.58% | +32.67% |
| 06-18 | Lipum AB Completes Multiple Dose Part of the Phase I Clinical Study | CI |
| 05-28 | Lipum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Lipum AB (publ) reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported revenue was SEK 0.115 million compared to SEK 0.472 million a year ago. Net loss was SEK 27.73 million compared to SEK 25.07 million a year ago.
Basic loss per share from continuing operations was SEK 3.38 compared to SEK 4.95 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +32.67% | 17.34M | |
| +2.87% | 94.22B | |
| -4.08% | 37.76B | |
| -13.80% | 32.5B | |
| +73.38% | 27.75B | |
| -11.65% | 16.13B | |
| -0.67% | 14.19B | |
| -11.67% | 11.42B | |
| +190.36% | 11.06B | |
| -52.61% | 9.09B |
LIPUM AB 
